@prefix this: . @prefix sub: . @prefix beldoc: . @prefix rdfs: . @prefix rdf: . @prefix xsd: . @prefix dct: . @prefix dce: . @prefix pav: . @prefix np: . @prefix belv: . @prefix prov: . @prefix schem: . @prefix RNA: . @prefix rgd: . @prefix geneProductOf: . @prefix species: . @prefix occursIn: . @prefix pubmed: . @prefix orcid: . sub:Head { this: np:hasAssertion sub:assertion; np:hasProvenance sub:provenance; np:hasPublicationInfo sub:pubinfo; a np:Nanopublication . } sub:assertion { sub:_1 geneProductOf: rgd:619757; a RNA: . sub:_2 occursIn: species:10116; rdf:object sub:_1; rdf:predicate belv:increases; rdf:subject schem:serum%20leptin; a rdf:Statement . sub:assertion rdfs:label "a(SCHEM:\"serum leptin\") -> r(RGD:Acox1)" . } sub:provenance { beldoc: dce:description "Approximately 61,000 statements."; dce:rights "Copyright (c) 2011-2012, Selventa. All rights reserved."; dce:title "BEL Framework Large Corpus Document"; pav:authoredBy sub:_4; pav:version "1.4" . sub:_3 prov:value "Ariadne: Furthermore, in the same cell system, leptin has been reported to upregulate the expression of acyl-CoA oxidase (ACO), carnitine palmitoyl transferase-1 (CPT1), and peroxisome proliferator- activated receptor-alpha (PPAR-alpha) [ 15 ], and to increase glucose decarboxylation [ 14 ] and lipolysis [ 13 , 15 , 17 , 18 ]."; prov:wasQuotedFrom pubmed:10998055 . sub:_4 rdfs:label "Selventa" . sub:assertion prov:hadPrimarySource pubmed:10998055; prov:wasDerivedFrom beldoc:, sub:_3 . } sub:pubinfo { this: dct:created "2014-07-03T14:29:52.456+02:00"^^xsd:dateTime; pav:createdBy orcid:0000-0001-6818-334X, orcid:0000-0002-1267-0234 . }